• Era of Personalized Medicine & Therapeutic Drug Monitoring in Autoimmune Diseases

    May 13 | Diagnostics World News | TNF-α inhibitors have been crucial in many diseases including IBD, psoriasis, cancer, and Alzheimer’s disease, among others. What exactly are we measuring to determine drug effectiveness and how can we, as clinicians, determine if these drugs are improving patient’s symptoms? More
  • St Jude Releases Early Data on Asymptomatic Cases Among Vaccinated Healthcare Workers

    May 12 | Diagnostics World News | In a research letter published last week in JAMA, St Jude Children’s Research Hospital researchers reported early findings tracking asymptomatic COVID-19 among vaccinated healthcare workers. The findings will inform both individual vaccination plans as well as institutional screening and testing programs. More
  • Ginkgo, Quest Collaborate To Expand In-School COVID-19 Pooled Testing

    May 07 | Diagnostics World News | Ginkgo Bioworks has added a collaboration with Quest Diagnostics to its existing network of COVID-19 testing labs. Quest Diagnostics has capacity to perform 300,000 COVID-19 PCR tests a day; the added capacity will give Ginkgo the capacity to test all 60 million US students, teachers and staff, every week. More
  • Quidel, Abbott Begin Rollout of At-Home COVID-19 Antigen Tests

    May 06 | Diagnostics World News | Quidel and Abbott have introduced at-home COVID-19 antigen tests that do not require a prescription and deliver results in just minutes. They are also completely independent of doctor oversight or reporting of results. More
  • New COVID-19 Diagnostics, Myriad Sells myPath, Nanoscale Diagnostic Sensors

    May 03 | Diagnostics World News | New sequencing project looks at developmental differences, Castle Biosciences to acquire Myriad’s myPath, AI tools for cystic fibrosis detection, updates in COVID-19 diagnostics, and more new products and updates from around the industry. More
  • New Business Direction for Qlucore, Preconception Genetics, and Genome Engineering

    Apr 29 | Diagnostics World News | New funding for rapid, easy-to-use PCR and near-patient sepsis diagnostics; a seed round for preconception genetic risk modeling; and a new business for Qlucore: cancer diagnostics. More
  • Could Activity Become A Vital Sign?

    Apr 26 | Diagnostics World News | Passive activity tracking could one day be used as a primary vital sign along with measures of body temperature, pulse, respiratory rate, and blood pressure. The “activity index” (Ai) of patients could be valuable to physicians when evaluating patients in the emergency room with vague complaints and deciding on degree of diagnostic testing. More
  • Aegis Expanded to COVID-19 Testing Supported By Expandable Infrastructure

    Apr 21 | Diagnostics World News | At the beginning of 2020, Aegis Sciences was a Nashville-based national toxicology lab, with a small biopharma lab. Today, they can do more than 110,000 COVID-19 tests per day. It’s been a busy year. More
  • Sema4, NorthShore Announce System-Wide Genomics, Research Partnership

    Apr 19 | Diagnostics World News | Sema4 has launched a strategic partnership with NorthShore University HealthSystem announcing the availability of a system-wide data-driven genomics program that uses predictive analytics to help clinicians and patients prevent, detect, and treat diseases at an early stage. More
  • Machine Learning Ranks Cancer Drugs Based On Proteome Of Tumors

    Apr 14 | Diagnostics World News | A UK company has released Drug Ranking Using Machine Learning (DRUML), an open-source ensemble of predictive models trained for drugs with different modes of action that can help clinicians pick the most appropriate cancer drugs for individual patients from among most (412 of 659) of the options now available. More
View more articles



Antigens & Antibodies for SARS-CoV-2 Diagnostic Kit Development

ACROBiosystems team has worked tirelessly since the genomic sequence of SARS-CoV-2 was first published, developing a serial of high-quality antigen and antibody reagents to support the development of the diagnostic kits. The products include the high quality S trimer, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity tested on several platforms.

Click to learn more about ACRO’s hot matched antibody pairs and antigens.